SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-023518
Filing Date
2019-11-14
Accepted
2019-11-14 16:53:45
Documents
47
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_wizepharma.htm 10-Q 453402
2 EXCLUSIVE LICENSE AGREEMENT (THE "LICENSE AGREEMENT") WITH COPERNICUS THERAPEUTI f10q0919ex10-1_wizepharma.htm EX-10.1 201162
3 AMENDMENT TO LICENSE AGREEMENT WITH RESDEVCO RESEARCH AND DEVELOPMENT COMPANY LT f10q0919ex10-2_wizepharma.htm EX-10.2 20868
4 RULE 13A-14(A) CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER** f10q0919ex31-1_wizepharma.htm EX-31.1 7716
5 RULE 13A-14(A) CERTIFICATION BY PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER** f10q0919ex31-2_wizepharma.htm EX-31.2 7721
6 RULE 13A-14(A) CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER** f10q0919ex32-1_wizepharma.htm EX-32.1 4199
7 RULE 13A-14(A) CERTIFICATION BY PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER** f10q0919ex32-2_wizepharma.htm EX-32.2 4233
  Complete submission text file 0001213900-19-023518.txt   2911665

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE wizp-20190930.xml EX-101.INS 470019
9 XBRL SCHEMA FILE wizp-20190930.xsd EX-101.SCH 34921
10 XBRL CALCULATION FILE wizp-20190930_cal.xml EX-101.CAL 32891
11 XBRL DEFINITION FILE wizp-20190930_def.xml EX-101.DEF 103443
12 XBRL LABEL FILE wizp-20190930_lab.xml EX-101.LAB 244778
13 XBRL PRESENTATION FILE wizp-20190930_pre.xml EX-101.PRE 175759
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 191221297
SIC: 2834 Pharmaceutical Preparations